Clinical Trial Update: An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an investigational drug (0653-062) to lower non-cholesterol sterol levels in sitosterolemia has completed. The document notes the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Sitosterolemia

Drugs mentioned

• Investigational drug 0653-062

Snippet

Sponsor: Organon and Co | Conditions: Lipid Metabolism, Inborn Errors, Heart Disease | Phase 3 | Status: COMPLETED